Author:
Zhao Ping,Xu Liming,Zhu Huijuan,Ding Wei,Tang Hui
Reference50 articles.
1. Oncogenic alterations in advanced NSCLC: a molecular super-highway;Friedlaender;Biomark. Res.,2024
2. Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment;Duma;Mayo Clin. Proc.,2019
3. Cancer statistics, 2020;Siegel;CA: A Cancer J. Clin.,2020
4. J.S.-K.A. Yuankai Shi, Sumitra Thongprasert, Sankar Srinivasan, Chun-Ming Tsai, Mai Trong Khoa, Karin Heeroma, Yohji Itoh, Gerardo Cornelio, Pan-Chyr Yang, A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER), J Thorac Oncol 9（2） (2014) 154-162. https://doi: 10.1097/JTO.0000000000000033.
5. Predicting tumor mutation burden and EGFR mutation using clinical and radiomic features in patients with malignant pulmonary nodules;Yin;J. Pers. Med.,2022